ClinicalTrials.gg
DrugBiological

Epratuzumab clinical trials

studies test it
27
open now
0
in phase 3
8
first study started
2001

How each study uses epratuzumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Epratuzumab
21
hLL2 (Epratuzumab)
2

Development codes

AMG 412
1

Studies by the year they started

26 studies that test it; most in 2010 (5)

Studies that test epratuzumab, by start year
YearStudies
20012
20021
20031
20041
20054
20062
20071
20083
20091
20105
20112
20121
20142

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
16
Phase 3
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 11

UCB Pharma (12) · Nantes University Hospital (2) · Alliance for Clinical Trials in Oncology (2) · Gilead Sciences (2) · Jonsson Comprehensive Cancer Center (2) · Charite University, Berlin, Germany (1) · Children's Oncology Group (1) · SWOG Cancer Research Network (1)

Often tested with

Tested in the same studies.

Clofarabine (1) · Cytarabine (1) · Yttrium Y-90 epratuzumab tetraxetan (1)

Studies

Open first, then newest update. How each study uses epratuzumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 27

See all 27 studies that test epratuzumab →

Codes

What other systems call epratuzumab · ClinicalTrials.gg INT004428

  • MeSH (NLM) C448700epratuzumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 3062P60MH9EPRATUZUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q3730737epratuzumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1887EpratuzumabOne source FDA
  • DrugBank DB04958One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.